A triple combination targeting epigenetic dysregulation and apoptotic resistance, comprising iadademstat (LSD1 inhibitor), azacitidine (a hypomethylating agent), and venetoclax (a BCL-2 inhibitor), is under investigation in a phase I trial for acute myeloid leukemia (NCT06357182)
Some patients prefer this, especially if they have recent labs from their primary care provider
Nature's Lab CoQ10 + Alpha Lipoic Acid + Acetyl L-Carnitine is a targeted formula designed to support cellular energy production, whole-body antioxidant defense, and cognitive function from the inside out.* Three clinically researched ingredients each working on a distinct physiological pathway combine into a single, clean daily capsule built around how your body actually generates and sustains energy at the cellular level.*
This is a very small amount that's unlikely to cause stimulant effects for most people
Model selection using modified AIC and BIC in joint modeling of paired functional data